Chimeric protein ABRaA-VEGF121 is cytotoxic towards VEGFR-2-expressing PAE cells and inhibits B16-F10 melanoma growth

Acta Biochimica Polonica

Volumn 56, Issue 1, 2009, Pages 115-124

  Smagur, Andrzej ^a   Boyko, Mariya M ^a   Biront, Nadiya V ^a   Cichoń, Tomasz ^a   Szala, Stanislaw ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Abrin a A chain; Chimeric protein; Melanoma B16 F10; VEGF121s

Indexed keywords

BACTERIA (MICROORGANISMS); MURINAE;

EID: 67249133008     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2009_2523     Document Type: Article

References (33)

1. Arora N, Masood R, Zheng T, Cai J, Smith DL, Gill PS (1999) Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells. Cancer Res 59: 183-188.
2. Backer MV, Budker VG, Backer JM (2001) Shiga-like toxin-VEGF fusion proteins are selectively cytotoxic to endothelial cells overexpressing VEGFR-2. J Control Release 74: 349-355.
3. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM (1996) Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97: 469-476.
4. Brown LF, Guidi AJ, Tognazzi K, Dvorak HF (1998) Vascular permeability factor/vascular endothelial growth factor and vascular stroma formation in neoplasia: insights from in situ hybridization studies. J Histochem Cytochem 46: 569-575.
5. Chow LP, Chou MH, Ho CY, Chuang CC, Pan FM, Wu SH, Lin JY (1999) Purification, characterization and molecular cloning of trichoanguin, a novel type I ribosome-inactivating protein from the seeds of Trichosanthes anguina. Biochem J 338: 211-219.
6. Dickers KJ, Bradberry SM, Rice P, Griffiths GD, Vale JA (2003) Abrin poisoning. Toxicol Rev 22: 137-142.
7. Endo Y, Mitsui K, Motizuki M, Tsurugi K (1987) The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28S ribosomal RNA caused by the toxins. J Biol Chem 262: 5908-5912.
8. Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438: 967-974.
9. Fodstad O, Olsnes S, Pihl A (1977) Inhibitory effect of abrin and ricin on the growth of transplantable murine tumors and of abrin on human cancers in nude mice. Cancer Res 37: 4559-4567.
10. Griffiths GD, Leek MD, Gee DJ (1987) The toxic plant proteins ricin and abrin induce apoptotic changes in mammalian lymphoid tissues and intestine. J Pathol 151: 221-229.
11. Gustafsson C, Govindarajan S, Minshull J (2004) Codon bias and heterologous protein expression. Trends Biotechnol 22: 346-353.
12. Hoeben A, Landuyt B, Highley MS, Wildiers H, van Oosterom AT, de Bruijn EA (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56: 549-580.
13. Hwang KM, Foon KA, Cheung PH, Pearson JW, Oldham R (1984) Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen. Cancer Res 44: 4578-4586.
14. Kowanets M, Ferrara N (2006) Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 12: 5018-5022.
15. 121 and the serine protease granzyme B: Directed apoptotic events in vascular endothelial cells. Mol Cancer Ther 2: 949-959.
16. Mitrus I, Missol-Kolka E, Plucienniczak A, Szala S (2005) Tumour therapy with genes encoding apoptin and E4orf4. Anticancer Res 25: 1087-1090.
17. Narayanan S, Surolia A, Karande AA (2004) Ribosome-inactivating protein and apoptosis: abrin causes cell death via mitochondrial pathway in Jurkat cells. Biochem J 377: 233-240.
18. Ohba H, Moriwaki S, Bakalowa R, Yasuda S, Yamasaki N (2004) Plant-derived abrin-a induces apoptosis in cultured leukemic cell lines by different mechanisms. Toxicol Appl Pharmacol 195: 182-193.
19. Olsnes S, Pihl A (1973) Isolation and properties of abrin: a toxic protein inhibiting protein synthesis. Evidence for different biological functions of its two constituent-peptide chains. Eur J Biochem 35: 179-185.
20. Olsnes S, Fernansez-Puentes C, Carrasco L, Vazquez D (1975) Ribosome inactivation by the toxic lectins abrin and ricin. Kinetic of the enzymatic activity of the toxin A-chains. Eur J Biochem 60: 281-288.
21. 121 and regulates endothelial cell migration and sprouting. J Biol Chem 282: 24049-24056.
22. Pastan I, Hassan RH, FitzGerald DJ, Kreitman RJ (2007) Immunotoxin treatment in cancer. Annu Rev Med 58: 221-237.
23. Qu X, Qing L (2004) Abrin induces HeLa cell apoptosis by cytochrome c release and caspase activation. J Biochem Mol Biol 37: 445-453.
24. Ran S, Huang X, Downes A, Thorpe PE (2003) Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy. Neoplasia 5: 297-307.
25. Shibuya M (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39: 469-478.
26. Shih S-F, Wu Y-H, Hung C-H, Yang H-Y, Lin J-Y (2001) Abrin triggers cell death by inactivation a thiol-specific antioxidant protein. J Biol Chem 276: 21870-21877.
27. Szala S (2004) Two-domain vascular disruptive agents in cancer therapy. Curr Cancer Drug Targets 4: 501-509.
28. Thorpe PE (2004) Vascular targeting agents as cancer therapeutics. Clin Cancer Res 10: 415-427.
29. 121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors. Proc Natl Acad Sci USA 99: 7866-7871.
30. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K (2000) Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 60: 203-212.
31. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin C (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988-26995.
32. Wang L, Kang L, Hu T, Wang J (2004) Abrin-a A chain expressed as soluble form in Escherichia coli from a PCR-synthesized gene is catalytically and functionally active. Biochemie 86: 327-333.
33. Wawrzynczak EJ, Cumber AJ, Herry RV, May J, Newell DR, Parnell GD, Worrell NR, Forrester JA (1990) Pharmacokinetics in the rat of a panel of immunotoxins made with abrin a chain, ricin a chain, gelonin, and momordin. Cancer Res 50: 7519-7526.